Welcome to LookChem.com Sign In|Join Free
  • or
L-Glutamic acid, N-(1-oxodecyl)is a chemical compound derived from the amino acid L-glutamic acid, which is an important neurotransmitter in the central nervous system. L-Glutamic acid, N-(1-oxodecyl)is characterized by the attachment of a decyl group to L-glutamic acid through a carbonyl bond, which imparts hydrophobic properties to the molecule. This unique structure allows L-Glutamic acid, N-(1-oxodecyl)to interact with lipid membranes, making it a promising candidate for biological research and pharmaceutical development. However, further research is required to fully explore its biological activities and potential therapeutic applications.

111276-71-2

Post Buying Request

111276-71-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

111276-71-2 Usage

Uses

Used in Biological Research:
L-Glutamic acid, N-(1-oxodecyl)is used as a research tool for studying the interactions between neurotransmitters and lipid membranes. Its hydrophobic properties enable it to bind to cellular membranes, providing insights into the mechanisms of neurotransmission and membrane dynamics.
Used in Pharmaceutical Development:
L-Glutamic acid, N-(1-oxodecyl)has potential applications in the development of novel therapeutic agents. Its unique structure and ability to interact with lipid membranes may be leveraged to design drugs targeting specific cellular pathways or receptors involved in various diseases.
Used in Drug Delivery Systems:
L-Glutamic acid, N-(1-oxodecyl)can be utilized in the design of drug delivery systems to improve the bioavailability and targeting of therapeutic agents. Its hydrophobic nature may facilitate the encapsulation of hydrophobic drugs, enhancing their solubility and stability in biological systems.
Used in Neurodegenerative Disease Research:
Given its structural similarity to L-glutamic acid, a neurotransmitter involved in various neurological processes, L-Glutamic acid, N-(1-oxodecyl)may be used in research aimed at understanding the role of glutamate in neurodegenerative diseases such as Alzheimer's and Parkinson's. Its hydrophobic properties could provide insights into the mechanisms of glutamate-mediated neuronal toxicity and potential therapeutic interventions.

Check Digit Verification of cas no

The CAS Registry Mumber 111276-71-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,2,7 and 6 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 111276-71:
(8*1)+(7*1)+(6*1)+(5*2)+(4*7)+(3*6)+(2*7)+(1*1)=92
92 % 10 = 2
So 111276-71-2 is a valid CAS Registry Number.

111276-71-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-(decanoylamino)pentanedioic acid

1.2 Other means of identification

Product number -
Other names L-Glutamic acid,N-(1-oxodecyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:111276-71-2 SDS

111276-71-2Downstream Products

111276-71-2Relevant academic research and scientific papers

Combinatorial synthesis and biological evaluation of library of small-molecule Ser/Thr-protein phosphatase inhibitors

Wipf, Peter,Cunningham, April,Rice, Robert L.,Lazo, John S.

, p. 165 - 177 (1997)

In eukaryotes, phosphorylation of serine, threonine, and tyrosine residues on proteins is a fundamental posttranslational regulatory process for such functions as signal transduction, gene transcription, RNA splicing, cellular adhesion, apoptosis, and cell cycle control. Based on functional groups present in natural product serine/threonine protein phosphatase (PSTPase) inhibitors, we have designed pharmacophore model 1 and demonstrated the feasibility of a combinatorial chemistry approach for the preparation of functional analogues of 1. Preliminary biological testing of 18 structural variants of 1 has identified two compounds with growth inhibitory activity against cultured human breast cancer cells. In vitro inhibition of the PSTPase PP2A was demonstrated with compound Id. Using flow cytometry we observed that compound If caused prominent inhibition in the G1 phase of the cell cycle. Thus, the combinatorial modifications of the minimal pharmacophore 1 can generate biologically interesting antiproliferative agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 111276-71-2